ADARx Pharmaceuticals, Inc. (ADRX) research

ADARx Pharmaceuticals, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$18.25
As of

ADARx Pharmaceuticals, Inc. (ADRX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-28.

As of . Source: SEC EDGAR filings for ADRX. Method and limitations.

SHARE THIS CARD

Share the ADRX intelligence card

A branded snapshot of ADRX: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion ADRX intelligence card preview
Post to X
COMPANY DOSSIER

See the full ADRX dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for ADRX on one page. Preview it with sample data, then open it live with a free account.

Preview the ADRX dossier

Active signals for ADRX

No recent signals on ADRX in the last 180 days.

FREE, NO ACCOUNT

Every signal on ADRX, as it fires

New filings, 13F moves and cross asset signals on ADRX land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, ADRX

Related tickers

See more ADRX signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ADRXand get the insider, 13F, options, and confluence read in one view.

Preview the ADRX dossier